One further wrinkle to your half the patients are on drug and half are on placebo comment. True but remember that half those on drug are on Rosuvastatin + Apabetalone and half are on Atorvastatin + Apabetalone. We all know from Assure that those two "on drug" subgroups may not respond uniformly. Who knows for sure how this might affect the timing of the FA.